Form 4 for LH Labcorp
Accepted 2024-03-29 00:00:00 ET · period of report 2024-03-27 · accession 0000920148-24-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-29 | 2024-03-28 | LH | van der Vaart Sandra D | EVP, CLO | S - Sale+OE | $216.74 | -3,553 | 7,637 | -32% | -$770.1K |
| D | 2024-03-29 | 2024-03-27 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +6,158 | 13.8K | +81% | — |
| D | 2024-03-29 | 2024-03-27 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $216.57 | -2,605 | 11.2K | -19% | -$564.2K |
| D | 2024-03-29 | 2024-03-27 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | -6,158 | 2,190 | -74% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-28 | S | D | 3,553 | $216.74 | 7,636.98 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-27 | M | A | 6,158 | — | 13,794.98 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. |
| 3 | Common | Common Stock | 2024-03-27 | F | D | 2,605 | $216.57 | 11,189.98 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2024-03-27 | M | D | 6,158 | — | 2,190 | D | — · — to — | 6,158 Common Stock | (F1) Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. (F5) This number reflects the aggregate number of RSUs held by the reporting person. (F4) As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024. |